W. Kauffmann

Ribavirin treatment of acute and chronic hepatitis E: a single‐centre experience

M. Manns, H. Wedemeyer, C. Bara, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.

H. Herbst, H. Orzechowski, E. Garbe, 2012, Neuro-oncology.

Early monotherapy with pegylated interferon alpha‐2b for acute hepatitis C infection: The HEP‐NET acute‐HCV‐II study

M. Manns, T. Berg, S. Zeuzem, 2006, Hepatology.

Ramipril-induced liver injury: case report and review of the literature.

E. Garbe, R. Kreutz, W. Kauffmann, 2013, American journal of hypertension.

Early monotherapy with pegylated interferon alfa–2b for acute hepatitis C infection: Final Results of the German HEP-NET Acute HCV II Study

M. Manns, T. Berg, S. Zeuzem, 2005 .

565 RIBAVIRIN TREATMENT OF HEV INFECTION IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS: WHICH PATIENTS NEED ANTIVIRAL THERAPY?

H. Wedemeyer, C. Bara, A. Haverich, 2012 .

Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.

H. Herbst, H. Orzechowski, E. Garbe, 2012, Neuro-oncology.